Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes

Doxorubicin is a widely used and effective chemotherapy drug. However, cardiac and skeletal muscle toxicity of doxorubicin limits its use. Inhibiting myostatin/activin signalling can prevent muscle atrophy, but its effects in chemotherapy-induced muscle wasting are unknown. In the present study we i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nissinen, T. A., Degerman, J., Räsänen, M., Poikonen, A. R., Koskinen, S., Mervaala, E., Pasternack, A., Ritvos, O., Kivelä, R., Hulmi, J. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036092/
https://www.ncbi.nlm.nih.gov/pubmed/27666826
http://dx.doi.org/10.1038/srep32695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036092/
https://www.ncbi.nlm.nih.gov/pubmed/27666826
http://dx.doi.org/10.1038/srep32695

Ejemplares similares